Valuation : Balchem Corporation

Market Cap 5.69B 4.9B 4.6B 4.2B 7.89B 541B 7.94B 54.49B 21.2B 274B 21.36B 20.89B 909B P/E 2026 *
33x
P/E 2027 * 31.7x
Enterprise Value 5.72B 4.93B 4.63B 4.22B 7.94B 545B 7.99B 54.83B 21.33B 276B 21.49B 21.02B 914B EV / Sales 2026 *
5.06x
EV / Sales 2027 * 4.72x
Free-Float
99.53%
Yield 2026 *
0.66%
Yield 2027 * 0.73%
1 day-1.80%
1 week-1.25%
Current month+4.62%
1 month+4.62%
3 months+12.15%
6 months-3.36%
Current year+14.30%
1 week 175.26
Extreme 175.255
181.74
1 month 169.84
Extreme 169.84
182.99
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 65.37
Extreme 65.37
186.03
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2015
Director of Finance/CFO 49 04/02/2019
Chief Tech/Sci/R&D Officer 56 01/10/2025
Director TitleAgeSince
Director/Board Member 63 16/09/2010
Chairman 61 01/01/2017
Director/Board Member 59 15/09/2015
Date Insider Type Main position Quantity % Market Cap. Importance
1/4/26 Other

Controller/Auditor

8,646 0.0270%
11/2/26 Free

Director

870 0.0027%
11/2/26 Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
-1.80%-1.25%+9.22%+24.76% 5.69B
-1.42%-1.54%+2.83%+53.72% 80.38B
-0.49%+2.43%+3.67%-23.30% 38.33B
-1.20%-0.55%-3.24%+11.33% 37.96B
+2.14%+5.38%-3.45%+19.25% 24.81B
-0.13%+2.33%+29.40%+18.89% 22.9B
+0.41%-4.11%+81.95%+26.14% 22.46B
-1.00%-1.66%-40.89%-41.74% 18.5B
-1.49%-4.28%+70.30%-31.83% 16.21B
-0.75%+0.85%+11.25%-4.12% 14.75B
Average -0.49%+0.49%+16.10%+5.31% 28.2B
Weighted average by Cap. -0.52%+1.22%+11.61%+14.70%

Financials

2026 *2027 *
Net sales 1.13B 974M 915M 835M 1.57B 108B 1.58B 10.84B 4.22B 54.6B 4.25B 4.16B 181B 1.2B 1.03B 967M 882M 1.66B 114B 1.67B 11.46B 4.46B 57.69B 4.49B 4.39B 191B
Net income 175M 151M 141M 129M 242M 16.64B 244M 1.68B 652M 8.44B 657M 642M 27.93B 182M 157M 147M 134M 253M 17.34B 254M 1.75B 679M 8.79B 684M 669M 29.11B
Net Debt 35.51M 30.58M 28.71M 26.21M 49.23M 3.38B 49.59M 340M 132M 1.71B 133M 130M 5.67B -39.68M -34.16M -32.08M -29.28M -55.01M -3.78B -55.4M -380M -148M -1.91B -149M -146M -6.34B
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,379
Date Price Change Volume
01/09/26 USD 175.29 -1.77% 44,782
28/08/26 USD 178.44 +0.33% 150,707
27/08/26 USD 177.86 -1.07% 110,620
26/08/26 USD 179.79 +0.16% 140,306
25/08/26 USD 179.50 +1.13% 202,577
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
178.44USD
Average target price
209.25USD
Spread / Average Target
+17.27%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock